Tg Therapeutics (TGTX) Return on Invested Capital (2013 - 2026)

Tg Therapeutics' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
• Return on Invested Capital was 0.01% for Q1 2026 at Tg Therapeutics, up from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2025 to a low of 0.0% in Q3 2024.
• Historically, Return on Invested Capital has averaged 0.0% across 4 years, with a median of 0.0% in 2025.
• The sharpest annual moves came in 2024 and 2025: Return on Invested Capital changed 0 bps in 2024, then gained 1 bps in 2025.
• A 4-year view of Return on Invested Capital shows it stood at 0.0% in 2023, then soared by 913 bps to 0.0% in 2024, then jumped by 341 bps to 0.01% in 2025, then advanced by 12 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.